Find your next paid study

Hartford HospitalNCT07766837

~$75 – $2,000

Actual pay is set by the research site.

Autism Spectrum DisorderDepressive DisorderAnxiety Disorders

Feasibility, Acceptability, and Preliminary Effectiveness of Cognitive Behavioral Therapy for Depression in Autistic Youth in Clinical Settings

The goal of this clinical trial is to learn if Cognitive Behavioral Therapy for Depression in Autistic Youth (CBT-DAY) can improve depressive symptoms and rela…

Children's Hospital Los AngelesNCT07755137

Actual pay is set by the research site.

Intraoperative Wound Irrigation for Pilonidal Disease: A Randomized Controlled Trial

The purpose of this study is to determine the best method for cleaning wounds during surgery for patients with Stage 3 pilonidal disease. The investigators wil…

Pilonidal Disease

Stanford UniversityNCT07417202

Actual pay is set by the research site.

Early Life Stress and Depression: Molecular and Functional Imaging

Severe childhood adversity accounts for a large portion of psychiatric illness, and an increased risk for major depressive disorder (MDD). For some individuals…

DepressionTrauma, Psychological

Mclean HospitalNCT04713722

Actual pay is set by the research site.

Phase 1

A Phase I Study of d-Limonene With Concurrent Radiation and Platinum Based Chemotherapy for Xerostomia Prevention in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

This study explores the safety of d-limonene, a commercially-available dietary supplement (food) as a potential therapeutic for the severe dry mouth (xerostomi…

Xerostomia

Stanford UniversityNCT04392622

~$150 – $3,000

Actual pay is set by the research site.

Post Market Clinical Study to Evaluate the Performance of the Versius Surgical System

The goal of this clinical trial is to learn how the Versius Surgical System, a robotic surgery device, works for gallbladder removal surgery (cholecystectomy) …

Cholecystectomy, Robotic

CMR Surgical LtdNCT07096856

~$10 – $1,050

Actual pay is set by the research site.

Phase 1

A Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcγRIIB), in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcγRIIB), in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors

Solid Tumor, Adult

BioInvent International ABNCT04219254

~$150 – $4,500

Actual pay is set by the research site.

Managing Excess Infant Energy Intake by Increasing Satiation Responsiveness in Dyadic Feeding Interactions

The researchers will study how babies respond to bottle nipples with different flow rates over a few days, and how this may affect how much milk they drink, th…

Childhood Obesity

University of MichiganNCT07665983

Actual pay is set by the research site.

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

The purpose of this research is (1) to identify disease specific walking-related digital biomarkers of disease severity, and (2) monitor longitudinal changes i…

Spinal Muscular Atrophy Type 3Duchenne Muscular Dystrophy (DMD)

Columbia UniversityNCT06839469

Actual pay is set by the research site.

Phase 4

Autonomic and Renal Contributions to Hypertension With Androgen Deprivation Therapy

This study plans to learn more about contributors to high blood pressure in men who undergo androgen deprivation therapy (ADT) to treat prostate cancer. Prosta…

Androgen Deprivation TherapyProstate CancerHypertension+2 more

Virginia Commonwealth UniversityNCT07848828

~$25 – $1,000

Actual pay is set by the research site.

Phase 3

A Randomized, Double-Blind, Placebo-Controlled Twelve-Week Fixed-Dose Study to Evaluate the Efficacy and Safety of Nalbuphine Extended-Release Tablets for the Treatment of Chronic Cough in Participants With Idiopathic Pulmonary Fibrosis

The primary purpose is to evaluate the safety and efficacy of NAL ER for the treatment of chronic cough in participants with IPF.

Idiopathic Pulmonary Fibrosis

Trevi TherapeuticsNCT07868419

~$50 – $2,100

Actual pay is set by the research site.

Phase 1

A Phase 1, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of the PTK7-Targeted Antibody-drug Conjugate DAY301 in Patients With Locally Advanced or Metastatic Solid Tumors

This is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety and anti-tumor activity of DAY301, a PTK7-directed antibody-drug …

Advanced or Metastatic Solid Tumors